Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Identify the lowest expense ratio among dividend etfs quickly and compare key funds side by side to guide your next investment move.
27,594 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
BitMine expands its Ethereum hoard to 60,000 ETH worth about $126 million as it enters the Russell 1000 preliminary l...
Institutions are increasingly weighing Bitcoin as a potential reserve asset alongside gold, amid macro uncertainty an...
Eagle Point Credit Company touts an 18% yield, yet its portfolio centers on CLO equity tranches—the most volatile seg...
Software shares rebound after April troughs, lifting the IGV ETF. CrowdStrike's upcoming results are the main catalys...
Fidelity has alerted owners of 500-stock funds that the S&P 500 is dominated by a small group of mega-caps, raising q...
JPMorgan argues the macro bet that fueled Bitcoin gains is cooling, with BTC near $63,000 as markets digest easing te...
NVIDIA's leadership and AI-driven demand are reshaping the stock market landscape. This article dives into what Jense...
Bitcoin trades near mid-$60k as the dollar strengthens on hawkish Fed signals, shaping a fresh bitcoin price predicti...
Nvidia surged into the spotlight as a long-term wealth engine for many investors. This guide asks the hard question: ...
Dogecoin remains near key support as the Musk-and-SpaceX narrative cools. Investors await fresh catalysts that could ...
Bitcoin faces a steep uphill climb after last year’s peak left early buyers in the red. Analysts say a near 90% rally...